Literature DB >> 2258704

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide.

A E Postlethwaite1, J M Seyer.   

Abstract

Macrophages are a major source of fibrogenic factors that promote healing of injured tissue. The recruitment of fibroblasts to sites of tissue injury is a prerequisite for optimal repair of tissue damage. In the present study, human recombinant tumor necrosis factor alpha (hrTNF-alpha), a major macrophage-derived cytokine, was demonstrated to be a potent fibroblast chemoattractant, inducing migration at picomolar concentrations. Anti-hrTNF-alpha monoclonal antibody neutralized most of the fibroblast chemotactic activity generated during short-term culture of human peripheral blood monocytes stimulated with bacterial lipopolysaccharide, suggesting that TNF-alpha is a major monocyte-derived fibroblast chemoattractant. The portion of the human TNF-alpha molecule responsible for its chemotactic stimulation of fibroblasts appears to reside in residues 31-68. This region is highly conserved between TNF-alpha and lymphotoxin. This peptide is not only itself chemotactic but is also able to block the chemotactic response of fibroblasts to hrTNF-alpha and vice versa, suggesting that they each mediate fibroblast migration through similar mechanisms. These data further underscore the potential importance of TNF-alpha in modulating a variety of fibroblast functions, including chemotaxis and synthesis of collagen, glycosaminoglycans, interleukin 1 alpha (IL-1 alpha) and -beta, human histocompatibility leukocyte antigen A and B antigens, collagenase, prostaglandin E2, and IL-6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258704      PMCID: PMC2188741          DOI: 10.1084/jem.172.6.1749

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

2.  Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.

Authors:  U Mrowietz; J M Schröder; E Christophers
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

3.  Expression and secretion of type beta transforming growth factor by activated human macrophages.

Authors:  R K Assoian; B E Fleurdelys; H C Stevenson; P J Miller; D K Madtes; E W Raines; R Ross; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse.

Authors:  R J Sharpe; R J Margolis; M Askari; E P Amento; R D Granstein
Journal:  J Invest Dermatol       Date:  1988-10       Impact factor: 8.551

5.  Fibroblast growth-stimulatory activity released from human monocytes. The contribution of tumour necrosis factor.

Authors:  R Austgulen; T Espevik; J Nissen-Meyer
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

6.  Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts.

Authors:  J M Le; D Weinstein; U Gubler; J Vilcek
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

7.  Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen.

Authors:  R S Aycock; R Raghow; G P Stricklin; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

8.  Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts.

Authors:  J A Solis-Herruzo; D A Brenner; M Chojkier
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

9.  Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

Authors:  M Kohase; D Henriksen-DeStefano; L T May; J Vilcek; P B Sehgal
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Authors:  A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 3.  Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.

Authors:  Brijen Shah; Lloyd Mayer
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

4.  Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy.

Authors:  G A Limb; A H Chignell; H Woon; W Green; C J Cole; D C Dumonde
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

5.  Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; H Soomro; S Janikoun; R D Hollifield; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 6.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

7.  Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors:  S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

8.  Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.

Authors:  Durairaj Punithavathi; Narayanan Venkatesan; Mary Babu
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

9.  Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline.

Authors:  Jianling Wang; Gangduo Wang; G A S Ansari; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-04       Impact factor: 4.219

10.  PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization.

Authors:  Dirk Haubert; Nina Gharib; Francisco Rivero; Katja Wiegmann; Marianna Hösel; Martin Krönke; Hamid Kashkar
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.